Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: A prospective survey of intravenous and subcutaneous use

American Journal of Hospice and Palliative Medicine

Volumn 23, Issue 5, 2006, Pages 353-359

  Walsh, Declan ^a,b   Perin, Mary Lou ^a   McIver, Beth ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Morphine; Pain

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; DRUG ADMINISTRATION; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEOPLASM; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PRESCRIPTION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, ORAL; ADULT; AGED; ANALGESICS, OPIOID; ATTITUDE TO HEALTH; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INPATIENTS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; OHIO; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 34247265628     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909106292170     Document Type: Article

References (11)

1. Stjernsward J. WHO cancer pain relief program. Cancer Surveys. 1988;7:195-208.
2. Nelson KA, Glare PA, Walsh D, Groh ES. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage. 1997;13:262-267.
3. Walsh TD, Smyth EM, Currie K, Glare PA, Schneider J. A pilot study, review of the literature, and dosing guidelines for patient-controlled analgesia using subcutaneous morphine sulphate for chronic cancer pain. Palliat Med. 1992;6:217-216.
4. Ferris FD, Kerr IG, De Angelis C, Sone M, Hume S. Inpatient narcotic infusions for patients with cancer pain. J Pall Care. 1990;6:51-59.
5. Stuart GJ, Davey EB, Wight SE. Continuous intravenous morphine infusions for terminal pain control: a retrospective review. Drug Intell Clin Pharm. 1986;20: 968-972.
6. Miser AW, Miser JS, Clark BS. Continuous IV infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr. 1980;96:930-932.
7. Fraser, DG. Intravenous morphine infusion for chronic pain. Ann Intern Med. 1980;93:781-782.
8. Citron ML, Johnston-Early A, Fossieck BE, et al. Safety and efficacy of continuous intravenous morphine for severe cancer pain. Am J Med. 1984;77:199-204.
9. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from study of opioid infusions. Pain. 1990;43:273-286.
10. Glare P, Walsh D, Groh E, Nelson KA. The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer. Am J Hospice Palliat Care. 2002;19:343-350.
11. Donnelly S, Davis MP, Walsh D, Naughton M. Morphine in cancer pain management: a practical guide. Support Care Cancer. 2002;10:13-35.